pEGFP-C1-ER alpha Citations (22)
Originally described in: Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA Mol Endocrinol. 2000 Apr . 14(4):518-34. PubMed Journal
Articles Citing pEGFP-C1-ER alpha
| Articles |
|---|
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, Li Z, Gala K, Fanning S, King TA, Hudis C, Chen D, Taran T, Hortobagyi G, Greene G, Berger M, Baselga J, Chandarlapaty S.
Nat Genet. 2013 Dec;45(12):1439-45. doi: 10.1038/ng.2822. Epub 2013 Nov 3.
PubMed
Associated Plasmids |
| Fluorescently-Labeled Estradiol Internalization and Membrane Trafficking in Live N-38 Neuronal Cells Visualized with Total Internal Reflection Fluorescence Microscopy. Kisler K, Chow RH, Dominguez R. J Steroids Horm Sci. 2013 Apr 20;Suppl 12. doi: 10.4172/2157-7536.S12-002. PubMed |
| Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway. Hou X, Zhao M, Wang T, Zhang G. Oncol Rep. 2014 Mar;31(3):1175-82. doi: 10.3892/or.2013.2944. Epub 2013 Dec 23. PubMed |
| Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101. Borges S, Perez EA, Thompson EA, Radisky DC, Geiger XJ, Storz P. Mol Cancer Ther. 2015 Jun;14(6):1306-16. doi: 10.1158/1535-7163.MCT-14-0945. Epub 2015 Apr 7. PubMed |
| PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer. Bosch A, Li Z, Bergamaschi A, Ellis H, Toska E, Prat A, Tao JJ, Spratt DE, Viola-Villegas NT, Castel P, Minuesa G, Morse N, Rodon J, Ibrahim Y, Cortes J, Perez-Garcia J, Galvan P, Grueso J, Guzman M, Katzenellenbogen JA, Kharas M, Lewis JS, Dickler M, Serra V, Rosen N, Chandarlapaty S, Scaltriti M, Baselga J. Sci Transl Med. 2015 Apr 15;7(283):283ra51. doi: 10.1126/scitranslmed.aaa4442. PubMed |
| Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides. Kucinska M, Giron MD, Piotrowska H, Lisiak N, Granig WH, Lopez-Jaramillo FJ, Salto R, Murias M, Erker T. PLoS One. 2016 Jan 5;11(1):e0145615. doi: 10.1371/journal.pone.0145615. eCollection 2016. PubMed |
| Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity. Mair B, Konopka T, Kerzendorfer C, Sleiman K, Salic S, Serra V, Muellner MK, Theodorou V, Nijman SM. PLoS Genet. 2016 Sep 2;12(9):e1006279. doi: 10.1371/journal.pgen.1006279. eCollection 2016 Sep. PubMed |
| Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1alpha to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease. Besse-Patin A, Leveille M, Oropeza D, Nguyen BN, Prat A, Estall JL. Gastroenterology. 2017 Jan;152(1):243-256. doi: 10.1053/j.gastro.2016.09.017. Epub 2016 Sep 20. PubMed |
| Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals. Huang J, Woods P, Normolle D, Goff JP, Benos PV, Stehle CJ, Steinman RA. Breast Cancer Res Treat. 2017 Jan;161(2):229-243. doi: 10.1007/s10549-016-4052-0. Epub 2016 Nov 16. PubMed |
| The cyclin-like protein, SPY1, regulates the ERalpha and ERK1/2 pathways promoting tamoxifen resistance. Ferraiuolo RM, Tubman J, Sinha I, Hamm C, Porter LA. Oncotarget. 2017 Apr 4;8(14):23337-23352. doi: 10.18632/oncotarget.15578. PubMed |
| Forkhead Box Transcription Factors of the FOXA Class Are Required for Basal Transcription of Angiotensin-Converting Enzyme 2. Pedersen KB, Chodavarapu H, Lazartigues E. J Endocr Soc. 2017 Apr 1;1(4):370-384. doi: 10.1210/js.2016-1071. Epub 2017 Mar 6. PubMed |
| A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ERalpha expression. Watanabe K, Yamamoto S, Sakaguti S, Isayama K, Oka M, Nagano H, Mizukami Y. Sci Rep. 2018 Oct 30;8(1):16000. doi: 10.1038/s41598-018-34290-1. PubMed |
| Identification of SEPTIN12 as a novel target of the androgen and estrogen receptors in human testicular cells. Kuo PL, Tseng JY, Chen HI, Wu CY, Omar HA, Wang CY, Cheng HY, Hsu CC, Fu TF, Teng YN. Biochimie. 2019 Mar;158:1-9. doi: 10.1016/j.biochi.2018.11.018. Epub 2018 Dec 1. PubMed |
| Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis. Lillo Osuna MA, Garcia-Lopez J, El Ayachi I, Fatima I, Khalid AB, Kumpati J, Slayden AV, Seagroves TN, Miranda-Carboni GA, Krum SA. Cancer Res. 2019 Mar 15;79(6):1054-1068. doi: 10.1158/0008-5472.CAN-18-1255. Epub 2018 Dec 28. PubMed |
| The 17beta-estradiol induced upregulation of the adhesion G-protein coupled receptor (ADGRG7) is modulated by ESRalpha and SP1 complex. Hassan A, Bagu ET, Levesque M, Patten SA, Benhadjeba S, Edjekouane L, Villemure I, Tremblay A, Moldovan F. Biol Open. 2019 Jan 14;8(1). pii: bio.037390. doi: 10.1242/bio.037390. PubMed |
| Estrogen receptor-alpha regulation of microRNA-590 targets FAM171A1-a modifier of breast cancer invasiveness. Sanawar R, Mohan Dan V, Santhoshkumar TR, Kumar R, Pillai MR. Oncogenesis. 2019 Jan 9;8(1):5. doi: 10.1038/s41389-018-0113-z. PubMed |
| HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1beta. Tawara K, Scott H, Emathinger J, Wolf C, LaJoie D, Hedeen D, Bond L, Montgomery P, Jorcyk C. Oncotarget. 2019 Mar 12;10(21):2068-2085. doi: 10.18632/oncotarget.26699. eCollection 2019 Mar 12. PubMed |
| Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer. Kano M, Kondo S, Wakisaka N, Wakae K, Aga M, Moriyama-Kita M, Ishikawa K, Ueno T, Nakanishi Y, Hatano M, Endo K, Sugimoto H, Kitamura K, Muramatsu M, Yoshizaki T. Int J Cancer. 2019 Sep 15;145(6):1547-1557. doi: 10.1002/ijc.32500. Epub 2019 Jun 22. PubMed |
| CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells. Nguyen Hoang AT, Hoe KL, Lee SJ. PLoS One. 2021 Apr 16;16(4):e0246264. doi: 10.1371/journal.pone.0246264. eCollection 2021. PubMed |
| Androgens increase excitatory neurogenic potential in human brain organoids. Kelava I, Chiaradia I, Pellegrini L, Kalinka AT, Lancaster MA. Nature. 2022 Feb;602(7895):112-116. doi: 10.1038/s41586-021-04330-4. Epub 2022 Jan 19. PubMed |
| Novel Estrogen Receptor Dimerization BRET-Based Biosensors for Screening Estrogenic Endocrine-Disrupting Chemicals. Choi G, Kang H, Suh JS, Lee H, Han K, Yoo G, Jo H, Shin YM, Kim TJ, Youn B. Biomater Res. 2024 Mar 7;28:0010. doi: 10.34133/bmr.0010. eCollection 2024. PubMed |
| All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells. El Habre R, Aoun R, Tahtouh R, Hilal G. BMC Cancer. 2024 May 21;24(1):615. doi: 10.1186/s12885-024-12379-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.